# US 2024/0391935 A1 · Macrocyclic compounds and uses thereof

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2024/0391935 A1
- Document ID: US20240391935A1
- Status: Published application
- Kind: A1
- Application number: 18/630,760
- Filed: 2024-04-09
- Published: 2024-11-28
- Earliest claimed: 2017-07-28
- Assignees: Turning Point Therapeutics, Inc.
- Applicants: Turning Point Therapeutics, Inc.
- Inventors: Jingrong Jean Cui; Evan W. Rogers; Jane Ung; Jeffrey Whitten; Dayong Zhai; Wei Deng; Xin Zhang; Zhongdong Huang; Jing Liu; Han Zhang
- Web page: https://patentgrep.com/patent/US20240391935A1

## CPC

- C07D 498/16: Peri-condensed systems
- A61P 35/00: Antineoplastic agents
- C07D 498/18: Bridged systems
- C07K 16/2863: {against receptors for growth factors, growth regulators}
- A61K 45/06: Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- C07D: HETEROCYCLIC COMPOUNDS (macromolecular compounds C08)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- C07K: PEPTIDES (peptides in foodstuffs A23; obtaining protein compositions for foodstuffs, working-up proteins for foodstuffs A23J; preparations for medicinal purposes A61K; peptides containing beta-lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D519/02; macromolecular compounds having statistically distributed amino acid units in their molecules, i.e. when the preparation does not provide for a specific; but for a random sequence of the amino acid units, homopolyamides and block copolyamides derived from amino acids C08G69/00; macromolecular products derived from proteins C08H1/00; preparation of glue or gelatine C09H; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N15/00; compositions for measuring or testing processes involving enzymes C12Q; investigation or analysis of biological material G01N33/00)
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)

## Abstract

The present disclosure relates to certain macrocyclic compounds that inhibit SRC and MET, and/or CSF1R, pharmaceutical compositions containing such compounds, and methods of using such compounds to treat cancer.

## Claims

### Claim at position 1

1-80. (canceled)

### Claim 81

A compound having the structure:
or a salt thereof.

### Claim 82 (depends on 81)

The compound of claim 81, having the structure:

### Claim 83

A compound having the structure:

### Claim 84

A compound having the structure:

### Claim 85 (depends on 84)

The compound of claim 84 having the structure:

### Claim 86 (depends on 84)

The compound of claim 84 having the structure:

### Claim 87 (depends on 84)

The compound of claim 84 having the structure:

### Claim 88 (depends on 84)

The compound of claim 84 having the structure:

### Claim 89 (depends on 84)

The compound of claim 84 having the structure:

### Claim 90 (depends on 84)

The compound of claim 84 having the structure:
